Drug Pipeline

Midostaurin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT02115295 Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute… Acute Biphenotypic Leukemia Recruiting
NCT03591510 A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety… FLT3-mutated Acute Myeloid Leukemia Active, Not Recruiting
Phase 1
NCT06313437 Revumenib in Combination With 7+3 + Midostaurin in AML Acute Myeloid Leukemia Recruiting
NCT00819546 RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis… Acute Myeloid Leukemia Active, Not Recruiting
Sponsors Running Midostaurin Trials
Richard Stone, MD (2) M.D. Anderson Cancer Center (1) Novartis Pharmaceuticals (1)
Disease Areas
Leukemia (4) Acute Myeloid Leukemia (AML) (4) Myelodysplastic Syndromes (MDS) (2)
Get alerts when Midostaurin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free